4//SEC Filing
TAKEDA PHARMACEUTICAL CO LTD 4
Accession 0001395064-22-000146
$TAKCIK 0001888012other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 5:47 PM ET
Size
9.5 KB
Accession
0001395064-22-000146
Insider Transaction Report
Form 4
HilleVax, Inc.HLVX
Takeda Vaccines, Inc.
10% Owner
Transactions
- Exercise of In-Money
Warrant (Right to Buy)
2022-11-30−5,883,500→ 0 total(indirect: See Explanation of Responses)Exercise: $0.00From: 2022-05-03Exp: 2031-07-02→ Common Stock (5,883,500 underlying) - Exercise of In-Money
Common Stock
2022-11-30+5,883,500→ 6,724,000 total(indirect: See Explanation of Responses)
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2022-11-30+5,883,500→ 6,724,000 total(indirect: See Explanation of Responses) - Exercise of In-Money
Warrant (Right to Buy)
2022-11-30−5,883,500→ 0 total(indirect: See Explanation of Responses)Exercise: $0.00From: 2022-05-03Exp: 2031-07-02→ Common Stock (5,883,500 underlying)
Footnotes (2)
- [F1]On November 30,2022, the Reporting Person exercised a Warrant to purchase 5,883,500 shares of the Issuers common stock with an exercise price of $0.0000595 per share.
- [F2]Takeda Pharmaceutical Company Limited has beneficial ownership of the reported securities, all of which are held directly by Takeda Vaccines, Inc., an indirect wholly-owned subsidiary of TakedaPharmaceutical Company Limited. Takeda Vaccines, Inc. is owned directly by Takeda Pharmaceuticals U.S.A., Inc., which is owned directly by both Takeda Pharmaceutical Company Limited (72.70%) andTakeda Pharmaceuticals International AG (27.30%). Takeda Pharmaceuticals International AG is a wholly-owned direct subsidiary of Takeda Pharmaceutical Company Limited.
Documents
Issuer
HilleVax, Inc.
CIK 0001888012
Entity typeother
Related Parties
1- filerCIK 0001395064
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 5:47 PM ET
- Size
- 9.5 KB